Validation of Nasal Potential Difference Measurements in Gut-Corrected CF Knockout Mice
Authors:
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 39 (4) , 490-496
Abstract
Attempts at correcting the nasal potential difference (PD) in cystic fibrosis (CF) mice have long been used in preclinical gene and small molecule therapy development. However, in general, CF mice suffer from intestinal disease, are runted, and have high mortality rates; they are therefore difficult to work with, especially if large numbers are required. Because of this, large-scale PD studies in CF mice have not been performed. Working with CF mice has become substantially easier after the generation of the gut-corrected CF-knockout mouse. Fatty acid–binding promoter (FABp)-mediated expression of CFTR in the gut, but not the airways, prevents the intestinal disease of the CF knockout mouse. This model has given us the unique opportunity to systematically study PDs in large numbers of CF mice. The nose, but not the lungs, of these animals mimic the bioelectric defect seen in humans. We have therefore assessed the bioelectrics of the respiratory epithelium comparing FABp-CF and wild-type mice. The large body of data gathered in CF and wild-type mice allowed us, for the first time, to establish power calculations that should inform sample sizes required in gene and small molecule therapy development. In addition, we address the important issues of intra-animal variability as well as intra- and inter-operator variability for scoring the traces, and the effect of age and sex on nasal PD in CF mice. These data should allow a more informed use of CF animals in future studies.Keywords
This publication has 19 references indexed in Scilit:
- Gene therapy progress and prospects: cystic fibrosisGene Therapy, 2006
- Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator ReconstitutionHuman Gene Therapy, 2004
- Airway gene transfer in mouse nasal-airways: importance of identification of epithelial type for assessment of gene transferGene Therapy, 2000
- Generation and characterization of a ΔF508 cystic fibrosis mouse modelNature Genetics, 1995
- In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic FibrosisHuman Gene Therapy, 1995
- Correction of Lethal Intestinal Defect in a Mouse Model of Cystic Fibrosis by Human CFTRScience, 1994
- Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humansNature, 1994
- Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant miceNature Genetics, 1993
- Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosisNature Genetics, 1992
- An Animal Model for Cystic Fibrosis Made by Gene TargetingScience, 1992